Determined to reduce the risk of bleedsAnalysts say Roche’s bispecific antibody Hemlibra will rock the US$15bn haemophilia A market, given that it may circumvent therapy resistance that affects the 30% of patients who form antibodies against … more ➔
User-driven early certainty: EPO steps backIt was too good to be true. Following harsh criticism from industry, the European Patent Office (EPO) drafted a widely applauded proposal to allow exemptions to its Early Certainty Initiative in Examination. … more ➔
A match made in ScandinaviaTwo listed Scandinavian biotech companies are about to merge into one. Medical Prognosis Institute A/S (Nasdaq First North Stockholm) in Denmark and Oncology Venture Sweden AB (Aktie Torget) in Sweden … more ➔
EC earmarks €97.6m for HorizonIn Brussels, European Commissioners Jyrki Katainen and Carlos Moedas proposed a budget increase of 25% for the next European Research and Innovation programme Horizon Europe (2021-27) compared to Horizon … more ➔
Microbial game-changersHow do novel technologies affect the world’s largest enzyme producer? At the GBS, European Biotechnology asked Thomas Videbaeck, PhD, COO and Executive VP Research, Innovation and Supply. more ➔
Expanding into the commercial supply spaceCelonic AG has pursued an ambitious expansion strategy in mammalian cell line contract manufacturing to establish Phase III and commercial supply by mid-2019. A new GMP facility in Heidelberg was acquired, … more ➔
Follow the money – from niche to normDespite seemingly insurmountable environmental challenges ahead and the many successes’ flaunted by big biorefinery projects, the wider business community remains stubbornly sceptical about developing … more ➔
Fighting AMR: turning the p(h)ageThe rapid development of antibiotic resistance has become a major public health issue that could soon kill 10 million people annually. One promising alternative to ineffective antibiotics has been around … more ➔
How fast food hijacks young genesAmericans and Europeans love fast food, even though doctors are now more certain than ever that the highly processed meals that go hand-in-hand with a hectic Western lifestyle are not a smart health … more ➔
GMP and new processes: be prepared for hasslePoor aseptic practices can rapidly ruin market supply of products outsourced for production. This year, Celltrion came under fire from FDA inspectors. At the end of January, the producer received a warning … more ➔
